Back to Investors
PV

PXN Ventures

Venture Capital

PXN Ventures is the venture capital arm of PXN Group, delivering investment programmes to support founders across sectors including deep tech, life sciences, and software.

Portfolio

3

companies


Portfolio companies

I

Imperagen

Imperagen engineers better enzymes faster using quantum physics and artificial intelligence.

RA

Rightbrain AI

Rightbrain AI enables services businesses to build and deploy AI agents without technical complexity.

S

ScrubMarine

ScrubMarine develops autonomous robotics to clean and inspect ship hulls.


Team

JJ

Jess Jackson

PraeSeed Lead

PE

Patricia El Jichi

Investment Manager

AB

Andy Barrow

Managing Director

SS

Sim Singh-Landa

Investment Director


Recent investments

Seed
£5.0M

The funding round was led by PXN Ventures with participation from IQ Capital and Northern Gritstone.

"What I see right now is that the companies that will make a radical difference in this emerging AI-driven future are all AI-native, lean on real world data, have genuine impact, and are fundamentally deep tech. Imperagen has each of those characteristics, combining them with outstanding people, phenomenal technology and the undeniable swagger you only get from Manchester. It was a no-brainer to join the team and lead this next stage in its growth."
— Guy Levy-Yurista, CEO
Seed
£3.0M

The round was led by NPIF II - PXN Equity Finance with participation from Salica, NYDIG and angel investors.

"Businesses are under pressure to adopt AI, but many are finding that the real challenge isn’t accessing the technology but actually deploying it safely and effectively. We’re helping traditional B2B services evolve into AI-native businesses by embedding agents into their core workflows. This removes friction, giving teams a single platform to build, deploy and govern intelligent tools without needing to rebuild their infrastructure or hire specialist developers."
— Peter Cheyne, Co-founder